Sunday, July 6, 2025 7/6/2025

Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome.

Award Number: R21AI142717
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/21/2018
PERIOD OF PERFORMANCE END DATE: 11/30/2021

Group Awards By:

View Award Description

Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome. - The clinical presentation of chronic fatigue syndrome (CFS) includes cognitive disturbances, debilitating fatigue, widespread pain and ﬂu-like symptoms which limit patients' ability to perform the activities of daily living and, as a consequence, drastically lowering their quality of life. While the underlying causes remain largely unknown, some studies do suggest that CFS might be caused by viral infections and exposure to environmental toxins. This illness is associated with an aberrant activation of immune responses and abnormal mitochondria function. Owing to the key role of lipids in modulating immune and mitochondria function, the current study will attempt to identify lipids associated with these functions as novel blood biomarkers of CFS. Recent studies show abnormal proﬁles of ω-3 and ω-6 polyunsaturated fatty acids (PUFA) in patients with CFS compared to controls. Levels of long-chain acylcarnitines are decreased in patients with CFS. Furthermore, alteration in ether phospholipid (PL) that are synthesized in peroxisomes were also altered in blood from CFS patients. We therefore hypothesize that lipids associated with modulating immune responses and mitochondria and peroxisome function may be indicative of the underlying biological perturbations of their functions in CFS. In this proposal, we will apply a highly versatile reverse phase capillary based liquid chromatography system coupled to a high resolution and high mass accuracy LTQ Orbitrap mass spectrometer to identify novel blood biomarkers of CFS. In addition, this study will focus on identifying lipid proﬁles associated with the severity and types of CFS symptoms, particularly focusing on cognitive problems, fatigue and pain. Given that women are at an increased risk of developing CFS, we will examine lipid proﬁles which may differ between women and men with CFS. We expect that proposed studies will pave the way for future investigations into understanding the role of lipid metabolism in CFS as it relates to immune and mitochondria disturbances observed in ill patients. Availability of lipid biomarkers which give an indication of the underlying pathology and related symptomatology will aid in providing personalized care to CFS patients where the level of care and interventions provided to ill patients is tailored based on the diagnostic classiﬁcation, symptom proﬁles and severity of illness.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $24,852 )
2023	2020	ROSKAMP INSTITUTE INC, THE	2040 WHITFIELD AVE	SARASOTA	FL	34243	MANATEE	USA	Allergy and Infectious Diseases Research	000	2	4/27/2023	NON-COMPETING CONTINUATION	$24,852
														Subtotal = $24,852

Issue Date FY: 2022 ( Subtotal = -$24,852 )
2022	2020	ROSKAMP INSTITUTE INC, THE	2040 WHITFIELD AVE	SARASOTA	FL	34243	MANATEE	USA	Allergy and Infectious Diseases Research	000	2	5/26/2022	NON-COMPETING CONTINUATION	-$24,852
														Subtotal = -$24,852

Issue Date FY: 2020 ( Subtotal = $197,454 )
2020	2020	ROSKAMP INSTITUTE INC, THE	2040 WHITFIELD AVE	SARASOTA	FL	34243	MANATEE	USA	Allergy and Infectious Diseases Research	000	2	11/26/2019	NON-COMPETING CONTINUATION	$197,454
														Subtotal = $197,454

Issue Date FY: 2019 ( Subtotal = $212,268 )
2019	2019	ROSKAMP INSTITUTE INC, THE	2040 WHITFIELD AVE	SARASOTA	FL	34243	MANATEE	USA	Allergy and Infectious Diseases Research	000	1	12/20/2018	NEW	$212,268
														Subtotal = $212,268

Grand Total All Awards = $409,722

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome.

Award Number: R21AI142717

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/21/2018

PERIOD OF PERFORMANCE END DATE: 11/30/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer